Key result
The provided text is a publisher's catalog and does not contain clinical research findings.
Design
Review
Authors
Loading...
Cilostazol use in vascular disease is supported by long-term experience; leaves open prospective validation in PCI.
Cilostazol is a phosphodiesterase type III inhibitor with antiplatelet and vasodilatory effects, used in peripheral arterial disease, cerebrovascular disease, and percutaneous coronary intervention.
Zheng et al. (2019) studied this question. The provided text is a publisher's catalog and does not contain clinical research findings.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: